Metabolic Dysfunction and Neurodegeneration: Pharmacological Strategies Targeting Diabetes-Associated Alzheimer's disease

Authors

  • Mohamed Elsayed Kelany, Noha Abbas Telep, Amira Mohammed Abdel Hamid, Huda Mohamed Miftah Gargoum Author

DOI:

https://doi.org/10.48047/ef3qzv81

Keywords:

Metabolic Dysfunction , Neurodegeneration, Diabetes, Alzheimer's disease

Abstract

Background: Alzheimer’s disease represents a leading cause of dementia worldwide and is increasingly recognized as a complex, 
multifactorial disorder extending beyond classical amyloid and tau pathologies. Growing epidemiological and mechanistic evidence highlights  type 2 diabetes mellitus as a major risk factor for cognitive 

Downloads

Download data is not yet available.

References

Biessels GJ, Despa F. Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nat RevEndocrinol. 2018;14(10):591–604.

Chatterjee S, Peters SA, Woodward M, et al. Type 2 diabetes as a risk factor for dementia in women compared with men: a pooled analysis of 2.3 million people. Diabetes Care. 2016;39(2):300–307.

Downloads

Published

2024-11-20

How to Cite

Metabolic Dysfunction and Neurodegeneration: Pharmacological Strategies Targeting Diabetes-Associated Alzheimer’s disease (Mohamed Elsayed Kelany, Noha Abbas Telep, Amira Mohammed Abdel Hamid, Huda Mohamed Miftah Gargoum , Trans.). (2024). Cuestiones De Fisioterapia, 53(03), 6852-6863. https://doi.org/10.48047/ef3qzv81